Dr. Donald P. Braun, Ph.D., Vice President of Clinical Research for Cancer Treatment Centers of America, received his Ph.D. in Microbiology/Immunology from the University of Illinois at the Medical Center. He has more than 25 years of research experience in immunology, microbiology, inflammatory diseases, oncology, cancer immunology and cancer immunotherapy. His focus has been on identifying biological and molecular targets intrinsic to cancer and applying targeted therapeutics against those processes.
Dr. Braun has served as an advisor to numerous public agencies concerned with cancer. He served on the Experimental Therapeutics Study Section of the National Cancer Institute. In addition, he served on the Experimental Immunology and Immunotherapy Study Section of the American Cancer Society – National Division. Most recently, he served as the Administrative Director of the Medical College of Ohio Cancer Institute and formerly as the Scientific Director of Rush Cancer Institute.
Dr. Braun has authored approximately 90 published peer-reviewed manuscripts, 20 reviews and book chapters, 130 abstracts, and co-edited one book devoted to the use of prostaglandin inhibitors in cancer immunotherapy.